The transcriptional upregulation of RRM1 and RRM2 has been consistently observed in pancreatic tumors resistant to gemcitabine [30-32] and pancreatic cancer cell lines [31]. The gene discussed is RRM1; the disease is familial pancreatic carcinoma.